Trustmark National Bank Trust Department’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $494K | Sell |
20,508
-397
| -2% | -$10.4K | 0.03% | 213 |
|
|
2026
Q1 | $587K | Sell |
20,905
-550
| -3% | -$14.6K | 0.04% | 192 |
|
|
2025
Q4 | $534K | Sell |
21,455
-162
| -0.7% | -$4.08K | 0.03% | 208 |
|
|
2025
Q3 | $551K | Sell |
21,617
-10,408
| -32% | -$257K | 0.04% | 205 |
|
|
2025
Q2 | $776K | Buy |
32,025
+6,078
| +23% | +$142K | 0.05% | 180 |
|
|
2025
Q1 | $657K | Sell |
25,947
-363
| -1% | -$9.5K | 0.05% | 183 |
|
|
2024
Q4 | $698K | Sell |
26,310
-7,233
| -22% | -$196K | 0.05% | 178 |
|
|
2024
Q3 | $971K | Buy |
33,543
+350
| +1% | +$10.2K | 0.07% | 162 |
|
|
2024
Q2 | $929K | Sell |
33,193
-2,792
| -8% | -$76.9K | 0.07% | 161 |
|
|
2024
Q1 | $999K | Sell |
35,985
-84,001
| -70% | -$2.33M | 0.08% | 161 |
|
|
2023
Q4 | $3.45M | Buy |
119,986
+43,265
| +56% | +$1.31M | 0.31% | 74 |
|
|
2023
Q3 | $2.54M | Sell |
76,721
-113
| -0.1% | -$4K | 0.25% | 81 |
|
|
2023
Q2 | $2.82M | Sell |
76,834
-5,870
| -7% | -$228K | 0.26% | 79 |
|
|
2023
Q1 | $3.37M | Sell |
82,704
-3,439
| -4% | -$149K | 0.31% | 71 |
|
|
2022
Q4 | $4.41M | Sell |
86,143
-4,249
| -5% | -$204K | 0.41% | 62 |
|
|
2022
Q3 | $3.96M | Sell |
90,392
-255
| -0.3% | -$12.4K | 0.38% | 61 |
|
|
2022
Q2 | $4.75M | Buy |
90,647
+1,093
| +1% | +$55.7K | 0.43% | 58 |
|
|
2022
Q1 | $4.64M | Sell |
89,554
-1,375
| -2% | -$71.3K | 0.37% | 66 |
|
|
2021
Q4 | $5.37M | Buy |
90,929
+2,252
| +3% | +$112K | 0.41% | 64 |
|
|
2021
Q3 | $3.81M | Sell |
88,677
-5,883
| -6% | -$261K | 0.31% | 81 |
|
|
2021
Q2 | $3.7M | Sell |
94,560
-3,400
| -3% | -$132K | 0.29% | 77 |
|
|
2021
Q1 | $3.55M | Sell |
97,960
-11,625
| -11% | -$413K | 0.3% | 75 |
|
|
2020
Q4 | $4.03M | Sell |
109,585
-26,124
| -19% | -$958K | 0.37% | 63 |
|
|
2020
Q3 | $4.72M | Buy |
135,709
+12,609
| +10% | +$442K | 0.47% | 53 |
|
|
2020
Q2 | $3.82M | Buy |
123,100
+6,451
| +6% | +$219K | 0.4% | 59 |
|
|
2020
Q1 | $3.61M | Sell |
116,649
-4,692
| -4% | -$160K | 0.43% | 57 |
|
|
2019
Q4 | $4.51M | Sell |
121,341
-2,695
| -2% | -$96K | 0.43% | 53 |
|
|
2019
Q3 | $4.23M | Sell |
124,036
-5,259
| -4% | -$191K | 0.41% | 55 |
|
|
2019
Q2 | $5.31M | Sell |
129,295
-5,074
| -4% | -$201K | 0.52% | 47 |
|
|
2019
Q1 | $5.41M | Sell |
134,369
-1,276
| -0.9% | -$51.1K | 0.55% | 42 |
|
|
2018
Q4 | $5.62M | Buy |
135,645
+3,965
| +3% | +$165K | 0.64% | 31 |
|
|
2018
Q3 | $5.51M | Buy |
131,680
+426
| +0.3% | +$16.4K | 0.55% | 42 |
|
|
2018
Q2 | $4.52M | Sell |
131,254
-234
| -0.2% | -$8K | 0.53% | 43 |
|
|
2018
Q1 | $4.43M | Sell |
131,488
-6,641
| -5% | -$228K | 0.48% | 50 |
|
|
2017
Q4 | $4.75M | Buy |
138,129
+3,097
| +2% | +$106K | 0.52% | 48 |
|
|
2017
Q3 | $4.57M | Sell |
135,032
-20,982
| -13% | -$674K | 0.52% | 51 |
|
|
2017
Q2 | $4.97M | Sell |
156,014
-13,113
| -8% | -$414K | 0.58% | 46 |
|
|
2017
Q1 | $5.49M | Buy |
169,127
+32,045
| +23% | +$1.01M | 0.66% | 40 |
|
|
2016
Q4 | $4.22M | Sell |
137,082
-172
| -0.1% | -$5.25K | 0.56% | 42 |
|
|
2016
Q3 | $4.41M | Sell |
137,254
-5,184
| -4% | -$173K | 0.54% | 46 |
|
|
2016
Q2 | $4.76M | Sell |
142,438
-2,637
| -2% | -$84.2K | 0.61% | 42 |
|
|
2016
Q1 | $4.08M | Buy |
145,075
+640
| +0.4% | +$18.3K | 0.56% | 44 |
|
|
2015
Q4 | $4.42M | Sell |
144,435
-8,154
| -5% | -$257K | 0.61% | 43 |
|
|
2015
Q3 | $4.55M | Buy |
152,589
+3,052
| +2% | +$97.9K | 0.64% | 40 |
|
|
2015
Q2 | $4.76M | Sell |
149,537
-7,581
| -5% | -$247K | 0.64% | 38 |
|
|
2015
Q1 | $5.19M | Buy |
157,118
+11,271
| +8% | +$358K | 0.69% | 31 |
|
|
2014
Q4 | $4.31M | Sell |
145,847
-36,381
| -20% | -$1.04M | 0.59% | 43 |
|
|
2014
Q3 | $5.11M | Sell |
182,228
-1,138
| -0.6% | -$31.9K | 0.72% | 33 |
|
|
2014
Q2 | $5.16M | Sell |
183,366
-10,240
| -5% | -$292K | 0.58% | 33 |
|
|
2014
Q1 | $5.9M | Sell |
193,606
-6,571
| -3% | -$196K | 0.68% | 25 |
|
|
2013
Q4 | $5.82M | Sell |
200,177
-7,023
| -3% | -$204K | 0.69% | 23 |
|
|
2013
Q3 | $5.65M | Sell |
207,200
-417
| -0.2% | -$11.3K | 0.7% | 22 |
|
|
2013
Q2 | $5.52M | Buy |
+207,617
| New | +$5.74M | 0.72% | 23 |
|
Other funds holding PFE
Trustmark National Bank Trust Department's PFE Position: Q2 2026 in Review
Trustmark National Bank Trust Department reduced its Pfizer (PFE) stake by 1.9% in Q2 2026, selling an estimated $10.4K and leaving 20,508 shares worth $494K. The position accounts for 0.03% of the portfolio, ranked #213.
Trustmark National Bank Trust Department first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.9M in Q1 2014. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Trustmark National Bank Trust Department held 20,508 shares of Pfizer worth $494K as of Q2 2026.
- Trustmark National Bank Trust Department sold 397 Pfizer shares in Q2 2026, an estimated $10.4K.
- Pfizer made up 0.03% of Trustmark National Bank Trust Department's portfolio in Q2 2026, its #213 holding.
- Trustmark National Bank Trust Department first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Trustmark National Bank Trust Department's Pfizer position peaked at $5.9M in Q1 2014.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Trustmark National Bank Trust Department's 13F filing for Q2 2026, filed 12 Aug 2026.